009 Prikazi.p65
ثبت نشده
چکیده
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
منابع مشابه
009 Prikazi.p65
H " ) $( ) ($ ! $ $# O( * ($ ( " )$ " ) ( " ) * ( + ! & $+ ( " + / " )$ $ 0$" $+ )$'$" 9 &$#( , +( K / ) ( $"$ )$ " + ( ) $+$/ 2! * + #( + ( " ! " $( !$ + *" + ! ) $ ( 6 "$* ( *+ " + + " + ( .+ + ! $" $ 0$" 6" * + +/ $! * ( + $ $ + !$ $!* ( " "$. " & ($! " + +$* & ( $" $ 8 $+ ( 4H$* $6 " + B " ( $" 5 + $ ( " , * ! $ *$ + 8 $+ ( ) $, $ ,$ $/ H$($( " !$, $ *" $ " + 8 $+$ ; 8 6 ) ; ( ( + ( "/ $ !$...
متن کامل11 Prikazi.p65
) # ! $ ( 5 H : % 0 ; # # A6 # AA # " # " " ' K $ % $ $ ! 1 ! $ # ' ! " ( ' # $ + # + B ! E ! ! ( , A6P $ # * + # H $ ! % A0 $ # " ! * $ " ! 7 # # * 9 + ! * K $ ! % ! ) # ! $ 7 ' 5 4 : 0 %66P ; ! # ! ! K $ H 4 + ! % ! ! + * H * 7 ! ! % # # " # ' ! K $ 1 ! ( ! * ! ( ! H & H ( $ * # ' $ ! # ! " ! # % # $ # 5 $ , I # ! # ! 2 $ ! ( * ! ' ( 2 $ # ' " ! ! ( $ ' ' ! " $ " ( # ! $ $ % ! * $ $ * * " ! #...
متن کامل[Effects of cernitin pollen extract (CN-009) on the isolated bladder smooth muscles and the intravesical pressure].
Cernitin pollen extract (CN-009), extract from several pollen species, has been used for urinary dysfunction. As its mode of action has not been clarified, we investigated the action of CN-009 on the isolated bladder smooth muscles of rats, guinea pigs and cats and the intravesical pressure in female rats. CN-009 contracted isolated detrusor muscles of rats, guinea pigs and cats in a concentrat...
متن کاملCancer Therapy: Clinical Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers
Purpose: MORAb-009 is a chimeric monoclonal antibody that targets mesothelin, a tumor differentiation antigen overexpressed in pancreatic cancer, ovarian cancer, mesothelioma, and other malignancies. We conducted a phase I clinical trial of MORAb-009 in patients with advanced mesothelin-expressing cancers to determine its safety, dose-limiting toxicity (DLT), and maximum tolerated dose (MTD). M...
متن کاملPhase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers.
PURPOSE MORAb-009 is a chimeric monoclonal antibody that targets mesothelin, a tumor differentiation antigen overexpressed in pancreatic cancer, ovarian cancer, mesothelioma, and other malignancies. We conducted a phase I clinical trial of MORAb-009 in patients with advanced mesothelin-expressing cancers to determine its safety, dose-limiting toxicity (DLT), and maximum tolerated dose (MTD). ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2006